Other Species / Isoforms
  Abi-1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y23-p
KRALIESyQNLTRVA
Upstream
0 188
Treatment
  • Su11274
Abi-1 (human) KRALIESyQNLTRVA Y23-p
Abi-1 iso2 (human) KRALIESYQNLTRVA Y23
Abi-1 iso3 (human) KRALIESYQNLTRVA Y23
Abi-1 iso11 (human) KRALIESYQNLTRVA Y23
Abi-1 iso12 (human) KRALIESYQNLTRVA Y23
Abi-1 (mouse) KRALIESyQNLTRVA Y23-p
Abi-1 iso4 (mouse) KRALIESYQNLTRVA Y23
Abi-1 (rat) KRALIESyQNLTRVA Y23-p
Y37-p
ADYCENNyIQATDkR
0 3
Abi-1 (human) ADYCENNyIQATDkR Y37-p
Abi-1 iso2 (human) ADYCENNYIQATDKR Y37
Abi-1 iso3 (human) ADYCENNYIQATDKR Y37
Abi-1 iso11 (human) ADYCENNYIQATDKR Y37
Abi-1 iso12 (human) ADYCENNYIQRHGFA Y37
Abi-1 (mouse) ADYCENNYIQATDKR Y37
Abi-1 iso4 (mouse) ADYCENNYIQATDKR Y37
Abi-1 (rat) ADYCENNYIQATDKR Y37
K43-ub
NyIQATDkRKALEET
0 2
Abi-1 (human) NyIQATDkRKALEET K43-ub
Abi-1 iso2 (human) NYIQATDKRKALEET K43
Abi-1 iso3 (human) NYIQATDKRKALEET K43
Abi-1 iso11 (human) NYIQATDKRKALEET K43
Abi-1 iso12 (human) SWPQATDKRKALEET K60
Abi-1 (mouse) NYIQATDKRKALEET K43
Abi-1 iso4 (mouse) NYIQATDKRKALEET K43
Abi-1 (rat) NYIQATDKRkALEET K43
K45
IQATDkRKALEETKA
0 1
Abi-1 (human) IQATDkRKALEETKA K45
Abi-1 iso2 (human) IQATDKRKALEETKA K45
Abi-1 iso3 (human) IQATDKRKALEETKA K45
Abi-1 iso11 (human) IQATDKRKALEETKA K45
Abi-1 iso12 (human) PQATDKRKALEETKA K62
Abi-1 (mouse) IQATDKRKALEETKA K45
Abi-1 iso4 (mouse) IQATDKRKALEETKA K45
Abi-1 (rat) IQATDKRkALEETKA K45-ac
S88-p
SQLRRMEsSINHISQ
1 1
Abi-1 (human) SQLRRMEsSINHISQ S88-p
Abi-1 iso2 (human) SQLRRMESSINHISQ S88
Abi-1 iso3 (human) SQLRRMESSINHISQ S88
Abi-1 iso11 (human) SQLRRMESSINHISQ S88
Abi-1 iso12 (human) SQLRRMESSINHISQ S105
Abi-1 (mouse) SQLRRMEsSINHISQ S88-p
Abi-1 iso4 (mouse) SQLRRMESSINHISQ S88
Abi-1 (rat) SQLRRMESSINHISQ S88
K116-ac
IGILTTNkNTSRTHk
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Abi-1 (human) IGILTTNkNTSRTHk K116-ac
Abi-1 iso2 (human) IGILTTNKNTSRTHK K116
Abi-1 iso3 (human) IGILTTNKNTSRTHK K116
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) IGILTTNKNTSRTHK K133
Abi-1 (mouse) IGILTTNKNTSRTHK K116
Abi-1 iso4 (mouse) IGILTTNKNTSRTHK K116
Abi-1 (rat) IGILTTNKNTSRTHK K116
K123-ub
kNTSRTHkIIAPANM
0 2
Abi-1 (human) kNTSRTHkIIAPANM K123-ub
Abi-1 iso2 (human) KNTSRTHKIIAPANM K123
Abi-1 iso3 (human) KNTSRTHKIIAPANM K123
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) KNTSRTHKIIAPANM K140
Abi-1 (mouse) KNTSRTHKIIAPANM K123
Abi-1 iso4 (mouse) KNTSRTHKIIAPANM K123
Abi-1 (rat) KNTSRTHKIIAPANM K123
K139-ub
RPVRYIRkPIDyTVL
0 2
Abi-1 (human) RPVRYIRkPIDyTVL K139-ub
Abi-1 iso2 (human) RPVRYIRKPIDYTVL K139
Abi-1 iso3 (human) RPVRYIRKPIDYTVL K139
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) RPVRYIRKPIDYTVL K156
Abi-1 (mouse) RPVRYIRKPIDYTVL K139
Abi-1 iso4 (mouse) RPVRYIRKPIDYTVL K139
Abi-1 (rat) RPVRYIRKPIDYTVL K139
Y143-p
YIRkPIDyTVLDDVG
0 3
Abi-1 (human) YIRkPIDyTVLDDVG Y143-p
Abi-1 iso2 (human) YIRKPIDYTVLDDVG Y143
Abi-1 iso3 (human) YIRKPIDYTVLDDVG Y143
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) YIRKPIDYTVLDDVG Y160
Abi-1 (mouse) YIRKPIDYTVLDDVG Y143
Abi-1 iso4 (mouse) YIRKPIDYTVLDDVG Y143
Abi-1 (rat) YIRKPIDYTVLDDVG Y143
K154
DDVGHGVKWLKAKHG
0 1
Abi-1 (human) DDVGHGVKWLKAKHG K154
Abi-1 iso2 (human) gap -
Abi-1 iso3 (human) DDVGHGVKWLKAKHG K154
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) DDVGHGVKWLKAKHG K171
Abi-1 (mouse) DDVGHGVkWLKAKHG K154-ub
Abi-1 iso4 (mouse) gap -
Abi-1 (rat) gap -
K159
GVKWLKAKHGNNQPA
0 1
Abi-1 (human) GVKWLKAKHGNNQPA K159
Abi-1 iso2 (human) DDVGHGVKHGNNQPA K154
Abi-1 iso3 (human) GVKWLKAKHGNNQPA K159
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) GVKWLKAKHGNNQPA K176
Abi-1 (mouse) GVkWLKAKHGNNQPA K159
Abi-1 iso4 (mouse) DDVGHGVkHGNNQPA K154-ub
Abi-1 (rat) DDVGHGVKHGNNQPA K154
T168-p
GNNQPARtGtLSRtN
0 2
Abi-1 (human) GNNQPARtGtLSRtN T168-p
Abi-1 iso2 (human) GNNQPARTGTLSRTN T163
Abi-1 iso3 (human) GNNQPARTGTLSRTN T168
Abi-1 iso11 (human) GNNQPARtGtLsRTN T104-p
Abi-1 iso12 (human) GNNQPARTGTLSRTN T185
Abi-1 (mouse) GNNQPARTGtLsRtN T168
Abi-1 iso4 (mouse) GNNQPARTGTLSRTN T163
Abi-1 (rat) GNNQPARTGTLSRTN T163
T170-p
NQPARtGtLSRtNPP
0 3
Abi-1 (human) NQPARtGtLSRtNPP T170-p
Abi-1 iso2 (human) NQPARTGTLSRTNPP T165
Abi-1 iso3 (human) NQPARTGTLSRTNPP T170
Abi-1 iso11 (human) NQPARtGtLsRTNPP T106-p
Abi-1 iso12 (human) NQPARTGTLSRTNPP T187
Abi-1 (mouse) NQPARTGtLsRtNPP T170-p
Abi-1 iso4 (mouse) NQPARTGTLSRTNPP T165
Abi-1 (rat) NQPARTGTLSRTNPP T165
S172
PARtGtLSRtNPPtQ
0 2
Abi-1 (human) PARtGtLSRtNPPtQ S172
Abi-1 iso2 (human) PARTGTLSRTNPPTQ S167
Abi-1 iso3 (human) PARTGTLSRTNPPTQ S172
Abi-1 iso11 (human) PARtGtLsRTNPPTQ S108-p
Abi-1 iso12 (human) PARTGTLSRTNPPTQ S189
Abi-1 (mouse) PARTGtLsRtNPPtQ S172-p
Abi-1 iso4 (mouse) PARTGTLSRTNPPTQ S167
Abi-1 (rat) PARTGTLSRTNPPTQ S167
T174-p
RtGtLSRtNPPtQKP
0 6
Abi-1 (human) RtGtLSRtNPPtQKP T174-p
Abi-1 iso2 (human) RTGTLSRTNPPTQKP T169
Abi-1 iso3 (human) RTGTLSRTNPPTQKP T174
Abi-1 iso11 (human) RtGtLsRTNPPTQKP T110
Abi-1 iso12 (human) RTGTLSRTNPPTQKP T191
Abi-1 (mouse) RTGtLsRtNPPtQKP T174-p
Abi-1 iso4 (mouse) RTGTLSRTNPPTQKP T169
Abi-1 (rat) RTGTLSRTNPPTQKP T169
T178-p
LSRtNPPtQKPPsPP
0 16
Abi-1 (human) LSRtNPPtQKPPsPP T178-p
Abi-1 iso2 (human) LSRTNPPTQKPPSPP T173
Abi-1 iso3 (human) LSRTNPPTQKPPSPP T178
Abi-1 iso11 (human) LsRTNPPTQKPPSPP T114
Abi-1 iso12 (human) LSRTNPPTQKPPSPP T195
Abi-1 (mouse) LsRtNPPtQKPPsPP T178-p
Abi-1 iso4 (mouse) LSRTNPPTQKPPSPP T173
Abi-1 (rat) LSRTNPPTQKPPsPP T173
S183-p
PPtQKPPsPPMsGRG
Upstream
Downstream
1 119
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell motility, altered
  • cytoskeletal reorganization
Kinase, in vitro:
  • ERK2 (human)
Putative in vivo kinases:
  • ERK1 (human)
  • ERK2 (human)
Treatment
  • EGF
  • serum_starvation
Abi-1 (human) PPtQKPPsPPMsGRG S183-p
Abi-1 iso2 (human) PPTQKPPSPPMSGRG S178
Abi-1 iso3 (human) PPTQKPPSPPMSGRG S183
Abi-1 iso11 (human) PPTQKPPSPPMSGRG S119
Abi-1 iso12 (human) PPTQKPPSPPMSGRG S200
Abi-1 (mouse) PPtQKPPsPPVsGRG S183-p
Abi-1 iso4 (mouse) PPTQKPPSPPVSGRG S178
Abi-1 (rat) PPTQKPPsPPVSGRG S178-p
S187-p
KPPsPPMsGRGtLGR
0 16
Abi-1 (human) KPPsPPMsGRGtLGR S187-p
Abi-1 iso2 (human) KPPSPPMSGRGTLGR S182
Abi-1 iso3 (human) KPPSPPMSGRGTLGR S187
Abi-1 iso11 (human) KPPSPPMSGRGTLGR S123
Abi-1 iso12 (human) KPPSPPMSGRGTLGR S204
Abi-1 (mouse) KPPsPPVsGRGtLGR S187-p
Abi-1 iso4 (mouse) KPPSPPVSGRGTLGR S182
Abi-1 (rat) KPPsPPVSGRGTLGR S182
T191-p
PPMsGRGtLGRNtPy
0 9
Abi-1 (human) PPMsGRGtLGRNtPy T191-p
Abi-1 iso2 (human) PPMSGRGTLGRNTPY T186
Abi-1 iso3 (human) PPMSGRGTLGRNTPY T191
Abi-1 iso11 (human) PPMSGRGTLGRNTPY T127
Abi-1 iso12 (human) PPMSGRGTLGRNTPY T208
Abi-1 (mouse) PPVsGRGtLGRNtPy T191-p
Abi-1 iso4 (mouse) PPVSGRGTLGRNTPY T186
Abi-1 (rat) PPVSGRGTLGRNTPy T186
T196-p
RGtLGRNtPyKtLEP
0 24
Abi-1 (human) RGtLGRNtPyKtLEP T196-p
Abi-1 iso2 (human) RGTLGRNTPYKTLEP T191
Abi-1 iso3 (human) RGTLGRNTPYKTLEP T196
Abi-1 iso11 (human) RGTLGRNTPYKTLEP T132
Abi-1 iso12 (human) RGTLGRNTPYKTLEP T213
Abi-1 (mouse) RGtLGRNtPyktLEP T196-p
Abi-1 iso4 (mouse) RGTLGRNTPYKTLEP T191
Abi-1 (rat) RGTLGRNTPyKTLEP T191
Y198-p
tLGRNtPyKtLEPVK
Upstream
0 485
Regulatory protein:
  • FGFR1 (human)
Treatment
  • ephrin_B1
  • FGF2
  • HGF
  • Su11274
Abi-1 (human) tLGRNtPyKtLEPVK Y198-p
Abi-1 iso2 (human) TLGRNTPYKTLEPVK Y193
Abi-1 iso3 (human) TLGRNTPYKTLEPVK Y198
Abi-1 iso11 (human) TLGRNTPYKTLEPVK Y134
Abi-1 iso12 (human) TLGRNTPYKTLEPVK Y215
Abi-1 (mouse) tLGRNtPyktLEPVk Y198-p
Abi-1 iso4 (mouse) TLGRNTPYKTLEPVK Y193
Abi-1 (rat) TLGRNTPyKTLEPVk Y193-p
K199
LGRNtPyKtLEPVKP
0 1
Abi-1 (human) LGRNtPyKtLEPVKP K199
Abi-1 iso2 (human) LGRNTPYKTLEPVKP K194
Abi-1 iso3 (human) LGRNTPYKTLEPVKP K199
Abi-1 iso11 (human) LGRNTPYKTLEPVKP K135
Abi-1 iso12 (human) LGRNTPYKTLEPVKP K216
Abi-1 (mouse) LGRNtPyktLEPVkP K199-ub
Abi-1 iso4 (mouse) LGRNTPYKTLEPVKP K194
Abi-1 (rat) LGRNTPyKTLEPVkP K194
T200-p
GRNtPyKtLEPVKPP
0 92
Abi-1 (human) GRNtPyKtLEPVKPP T200-p
Abi-1 iso2 (human) GRNTPYKTLEPVKPP T195
Abi-1 iso3 (human) GRNTPYKTLEPVKPP T200
Abi-1 iso11 (human) GRNTPYKTLEPVKPP T136
Abi-1 iso12 (human) GRNTPYKTLEPVKPP T217
Abi-1 (mouse) GRNtPyktLEPVkPP T200-p
Abi-1 iso4 (mouse) GRNTPYKTLEPVKPP T195
Abi-1 (rat) GRNTPyKTLEPVkPP T195
K205
yKtLEPVKPPtVPND
0 1
Abi-1 (human) yKtLEPVKPPtVPND K205
Abi-1 iso2 (human) YKTLEPVKPPTVPND K200
Abi-1 iso3 (human) YKTLEPVKPPTVPND K205
Abi-1 iso11 (human) YKTLEPVKPPTVPND K141
Abi-1 iso12 (human) YKTLEPVKPPTVPND K222
Abi-1 (mouse) yktLEPVKPPTVPND K205
Abi-1 iso4 (mouse) YKTLEPVKPPTVPND K200
Abi-1 (rat) yKTLEPVkPPTVPND K200-ac
K205
yKtLEPVKPPtVPND
0 1
Abi-1 (human) yKtLEPVKPPtVPND K205
Abi-1 iso2 (human) YKTLEPVKPPTVPND K200
Abi-1 iso3 (human) YKTLEPVKPPTVPND K205
Abi-1 iso11 (human) YKTLEPVKPPTVPND K141
Abi-1 iso12 (human) YKTLEPVKPPTVPND K222
Abi-1 (mouse) yktLEPVkPPTVPND K205-ub
Abi-1 iso4 (mouse) YKTLEPVKPPTVPND K200
Abi-1 (rat) yKTLEPVKPPTVPND K200
T208-p
LEPVKPPtVPNDyMt
0 5
Abi-1 (human) LEPVKPPtVPNDyMt T208-p
Abi-1 iso2 (human) LEPVKPPTVPNDYMT T203
Abi-1 iso3 (human) LEPVKPPTVPNDYMT T208
Abi-1 iso11 (human) LEPVKPPTVPNDYMT T144
Abi-1 iso12 (human) LEPVKPPTVPNDYMT T225
Abi-1 (mouse) LEPVkPPTVPNDyMt T208
Abi-1 iso4 (mouse) LEPVKPPTVPNDYMT T203
Abi-1 (rat) LEPVkPPTVPNDyMt T203
Y213-p
PPtVPNDyMtsPARL
Upstream
Downstream
5 715
Effects on Modified Protein
  • molecular association, regulation
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • endocytosis, altered
  • signaling pathway regulation
Kinase, in vitro:
  • Abl (human)
Putative in vivo kinases:
  • Abl (human)
Regulatory protein:
  • Abl (human)
  • Bcr (human)
Treatment
  • ephrin_B1
  • ephrin_B2
  • erlotinib
  • HGF
  • imatinib
  • Su11274
  • vanadate
Abi-1 (human) PPtVPNDyMtsPARL Y213-p
Abi-1 iso2 (human) PPTVPNDYMTSPARL Y208
Abi-1 iso3 (human) PPTVPNDYMTSPARL Y213
Abi-1 iso11 (human) PPTVPNDYMTSPARL Y149
Abi-1 iso12 (human) PPTVPNDYMTSPARL Y230
Abi-1 (mouse) PPTVPNDyMtsPARL Y213-p
Abi-1 iso4 (mouse) PPTVPNDYMTSPARL Y208
Abi-1 (rat) PPTVPNDyMtSPARL Y208-p
T215-p
tVPNDyMtsPARLGs
0 60
Abi-1 (human) tVPNDyMtsPARLGs T215-p
Abi-1 iso2 (human) TVPNDYMTSPARLGS T210
Abi-1 iso3 (human) TVPNDYMTSPARLGS T215
Abi-1 iso11 (human) TVPNDYMTSPARLGS T151
Abi-1 iso12 (human) TVPNDYMTSPARLGS T232
Abi-1 (mouse) TVPNDyMtsPARLGs T215-p
Abi-1 iso4 (mouse) TVPNDYMTSPARLGS T210
Abi-1 (rat) TVPNDyMtSPARLGs T210-p
S216-p
VPNDyMtsPARLGsQ
Upstream
Downstream
3 43
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, induced
  • cell motility, altered
  • cytoskeletal reorganization
  • signaling pathway regulation
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
  • ERK1 (human)
  • ERK2 (human)
Treatment
  • EGF
  • nocodazole
  • seliciclib
  • serum_starvation
Abi-1 (human) VPNDyMtsPARLGsQ S216-p
Abi-1 iso2 (human) VPNDYMTSPARLGSQ S211
Abi-1 iso3 (human) VPNDYMTSPARLGSQ S216
Abi-1 iso11 (human) VPNDYMTSPARLGSQ S152
Abi-1 iso12 (human) VPNDYMTSPARLGSQ S233
Abi-1 (mouse) VPNDyMtsPARLGsQ S216-p
Abi-1 iso4 (mouse) VPNDYMTSPARLGSQ S211
Abi-1 (rat) VPNDyMtSPARLGsQ S211
S222-p
tsPARLGsQHsPGRt
Upstream
0 116
Treatment
  • angiotensin_2
  • dasatinib
  • ischemia
  • metastatic potential
  • nocodazole
Abi-1 (human) tsPARLGsQHsPGRt S222-p
Abi-1 iso2 (human) TSPARLGSQHSPGRT S217
Abi-1 iso3 (human) TSPARLGSQHSPGRT S222
Abi-1 iso11 (human) TSPARLGSQHSPGRT S158
Abi-1 iso12 (human) TSPARLGSQHSPGRT S239
Abi-1 (mouse) tsPARLGsQHsPGRt S222-p
Abi-1 iso4 (mouse) TSPARLGSQHSPGRT S217
Abi-1 (rat) tSPARLGsQHsPGRT S217-p
S225-p
ARLGsQHsPGRtAsL
Upstream
Downstream
2 152
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell motility, altered
  • cell motility, induced
  • cytoskeletal reorganization
Kinase, in vitro:
  • ERK2 (human)
Putative in vivo kinases:
  • ERK1 (human)
  • ERK2 (human)
Regulatory protein:
  • JAM-A (human)
Treatment
  • CI1040
  • EGF
  • ischemia
  • metastatic potential
  • nocodazole
  • PP2
  • rapamycin
  • serum_starvation
  • U0126
  • wortmannin
Abi-1 (human) ARLGsQHsPGRtAsL S225-p
Abi-1 iso2 (human) ARLGSQHSPGRTASL S220
Abi-1 iso3 (human) ARLGSQHSPGRTASL S225
Abi-1 iso11 (human) ARLGSQHSPGRTASL S161
Abi-1 iso12 (human) ARLGSQHSPGRTASL S242
Abi-1 (mouse) ARLGsQHsPGRtAsL S225-p
Abi-1 iso4 (mouse) ARLGSQHSPGRTASL S220
Abi-1 (rat) ARLGsQHsPGRTAsL S220-p
T229-p
sQHsPGRtAsLNQRP
0 13
Abi-1 (human) sQHsPGRtAsLNQRP T229-p
Abi-1 iso2 (human) SQHSPGRTASLNQRP T224
Abi-1 iso3 (human) SQHSPGRTASLNQRP T229
Abi-1 iso11 (human) SQHSPGRTASLNQRP T165
Abi-1 iso12 (human) SQHSPGRTASLNQRP T246
Abi-1 (mouse) sQHsPGRtAsLNQRP T229-p
Abi-1 iso4 (mouse) SQHSPGRTASLNQRP T224
Abi-1 (rat) sQHsPGRTAsLNQRP T224
S231-p
HsPGRtAsLNQRPRt
Upstream
0 51
Treatment
  • PI-103
  • rapamycin
  • Su11274
  • wortmannin
Abi-1 (human) HsPGRtAsLNQRPRt S231-p
Abi-1 iso2 (human) HSPGRTASLNQRPRT S226
Abi-1 iso3 (human) HSPGRTASLNQRPRt S231
Abi-1 iso11 (human) HSPGRTASLNQRPRT S167
Abi-1 iso12 (human) HSPGRTASLNQRPRT S248
Abi-1 (mouse) HsPGRtAsLNQRPRT S231-p
Abi-1 iso4 (mouse) HSPGRTASLNQRPRT S226
Abi-1 (rat) HsPGRTAsLNQRPRT S226-p
T238-p
sLNQRPRtHsGssGG
0 4
Abi-1 (human) sLNQRPRtHsGssGG T238-p
Abi-1 iso2 (human) SLNQRPRTHSGSSGG T233
Abi-1 iso3 (human) SLNQRPRtHsGsSGG T238-p
Abi-1 iso11 (human) SLNQRPRTHSGSSGG T174
Abi-1 iso12 (human) SLNQRPRTHSGSSGG T255
Abi-1 (mouse) sLNQRPRTHsGSsGG T238
Abi-1 iso4 (mouse) SLNQRPRTHsGsSGG T233
Abi-1 (rat) sLNQRPRTHSGSSGG T233
S240-p
NQRPRtHsGssGGsG
0 65
Abi-1 (human) NQRPRtHsGssGGsG S240-p
Abi-1 iso2 (human) NQRPRTHSGSSGGsG S235
Abi-1 iso3 (human) NQRPRtHsGsSGGSG S240-p
Abi-1 iso11 (human) NQRPRTHSGSSGGSG S176
Abi-1 iso12 (human) NQRPRTHSGSSGGSG S257
Abi-1 (mouse) NQRPRTHsGSsGGSG S240-p
Abi-1 iso4 (mouse) NQRPRTHsGsSGGSG S235-p
Abi-1 (rat) NQRPRTHSGSSGGSG S235
S242-p
RPRtHsGssGGsGsR
0 54
Abi-1 (human) RPRtHsGssGGsGsR S242-p
Abi-1 iso2 (human) RPRTHSGSSGGsGSR S237
Abi-1 iso3 (human) RPRtHsGsSGGSGsR S242-p
Abi-1 iso11 (human) RPRTHSGSSGGSGSR S178
Abi-1 iso12 (human) RPRTHSGSSGGSGSR S259
Abi-1 (mouse) RPRTHsGSsGGSGSR S242
Abi-1 iso4 (mouse) RPRTHsGsSGGSGsR S237-p
Abi-1 (rat) RPRTHSGSSGGSGSR S237
S243-p
PRtHsGssGGsGsRE
0 5
Abi-1 (human) PRtHsGssGGsGsRE S243-p
Abi-1 iso2 (human) PRTHSGSSGGsGSRE S238
Abi-1 iso3 (human) PRtHsGsSGGSGsRE S243
Abi-1 iso11 (human) PRTHSGSSGGSGSRE S179
Abi-1 iso12 (human) PRTHSGSSGGSGSRE S260
Abi-1 (mouse) PRTHsGSsGGSGSRE S243-p
Abi-1 iso4 (mouse) PRTHsGsSGGSGsRE S238
Abi-1 (rat) PRTHSGSSGGSGSRE S238
S246-p
HsGssGGsGsRENsG
0 8
Abi-1 (human) HsGssGGsGsRENsG S246-p
Abi-1 iso2 (human) HSGSSGGsGSRENSG S241-p
Abi-1 iso3 (human) HsGsSGGSGsRENsG S246
Abi-1 iso11 (human) HSGSSGGSGSRENSG S182
Abi-1 iso12 (human) HSGSSGGSGSRENSG S263
Abi-1 (mouse) HsGSsGGSGSRENSG S246
Abi-1 iso4 (mouse) HsGsSGGSGsRENsG S241
Abi-1 (rat) HSGSSGGSGSRENSG S241
S248-p
GssGGsGsRENsGSS
0 5
Abi-1 (human) GssGGsGsRENsGSS S248-p
Abi-1 iso2 (human) GSSGGsGSRENSGSS S243
Abi-1 iso3 (human) GsSGGSGsRENsGss S248-p
Abi-1 iso11 (human) GSSGGSGSRENSGSS S184
Abi-1 iso12 (human) GSSGGSGSRENSGSS S265
Abi-1 (mouse) GSsGGSGSRENSGSS S248
Abi-1 iso4 (mouse) GsSGGSGsRENsGsS S243-p
Abi-1 (rat) GSSGGSGSRENSGSS S243
S252-p
GsGsRENsGSSSIGI
0 4
Abi-1 (human) GsGsRENsGSSSIGI S252-p
Abi-1 iso2 (human) GsGSRENSGSSSIGI S247
Abi-1 iso3 (human) GSGsRENsGssSIGI S252-p
Abi-1 iso11 (human) GSGSRENSGSSSIGI S188
Abi-1 iso12 (human) GSGSRENSGSSSIGI S269
Abi-1 (mouse) GSGSRENSGSSSIGI S252
Abi-1 iso4 (mouse) GSGsRENsGsSSIGI S247-p
Abi-1 (rat) GSGSRENSGSSSIGI S247
S254
GsRENsGSSSIGIPI
0 4
Abi-1 (human) GsRENsGSSSIGIPI S254
Abi-1 iso2 (human) GSRENSGSSSIGIPI S249
Abi-1 iso3 (human) GsRENsGssSIGIPI S254-p
Abi-1 iso11 (human) GSRENSGSSSIGIPI S190
Abi-1 iso12 (human) GSRENSGSSSIGIPI S271
Abi-1 (mouse) GSRENSGSSSIGIPI S254
Abi-1 iso4 (mouse) GsRENsGsSSIGIPI S249-p
Abi-1 (rat) GSRENSGSSSIGIPI S249
S255
sRENsGSSSIGIPIA
0 1
Abi-1 (human) sRENsGSSSIGIPIA S255
Abi-1 iso2 (human) SRENSGSSSIGIPIA S250
Abi-1 iso3 (human) sRENsGssSIGIPIA S255-p
Abi-1 iso11 (human) SRENSGSSSIGIPIA S191
Abi-1 iso12 (human) SRENSGSSSIGIPIA S272
Abi-1 (mouse) SRENSGSSSIGIPIA S255
Abi-1 iso4 (mouse) sRENsGsSSIGIPIA S250
Abi-1 (rat) SRENSGSSSIGIPIA S250
T265-p
GIPIAVPtPsPPTIG
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell motility, altered
  • cytoskeletal reorganization
Putative in vivo kinases:
  • ERK1 (human)
  • ERK2 (human)
Abi-1 (human) GIPIAVPtPsPPTIG T265-p
Abi-1 iso2 (human) GIPIAVPTPSPPTIG T260
Abi-1 iso3 (human) GIPIAVPtPsPPtIG T265-p
Abi-1 iso11 (human) GIPIAVPTPSPPTIG T201
Abi-1 iso12 (human) GIPIAVPTPSPPTIG T282
Abi-1 (mouse) GIPIAVPTPSPPTAG T265
Abi-1 iso4 (mouse) GIPIAVPTPSPPtAG T260
Abi-1 (rat) GIPIAVPTPSPPTAG T260
S267-p
PIAVPtPsPPTIGPE
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell motility, altered
  • cytoskeletal reorganization
Putative in vivo kinases:
  • ERK1 (human)
  • ERK2 (human)
Abi-1 (human) PIAVPtPsPPTIGPE S267-p
Abi-1 iso2 (human) PIAVPTPSPPTIGPA S262
Abi-1 iso3 (human) PIAVPtPsPPtIGPA S267-p
Abi-1 iso11 (human) PIAVPTPSPPTIGPV S203
Abi-1 iso12 (human) PIAVPTPSPPTIGPE S284
Abi-1 (mouse) PIAVPTPSPPTAGPA S267
Abi-1 iso4 (mouse) PIAVPTPSPPtAGPA S262
Abi-1 (rat) PIAVPTPSPPTAGPA S262
T270
VPtPsPPTIGPENIS
0 2
Abi-1 (human) VPtPsPPTIGPENIS T270
Abi-1 iso2 (human) VPTPSPPTIGPAPGS T265
Abi-1 iso3 (human) VPtPsPPtIGPAAPG T270-p
Abi-1 iso11 (human) VPTPSPPTIGPVADS T206
Abi-1 iso12 (human) VPTPSPPTIGPENIS T287
Abi-1 (mouse) VPTPSPPTAGPAAPG T270
Abi-1 iso4 (mouse) VPTPSPPtAGPAPGA T265-p
Abi-1 (rat) VPTPSPPTAGPAAPG T265
S305
TVIAAPGSAPGSQYG
0 1
Abi-1 (human) TVIAAPGSAPGSQYG S305
Abi-1 iso2 (human) TIGPAPGSAPGsQYG S272
Abi-1 iso3 (human) IGPAAPGsAPGsQyG S278-p
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) TVIAAPGSAPGSQYG S322
Abi-1 (mouse) AGPAAPGAAPGSQYG A278
Abi-1 iso4 (mouse) tAGPAPGAAPGSQyG A272
Abi-1 (rat) AGPAAPGAAPGSQYG A273
S309
APGSAPGSQYGTMTR
0 9
Abi-1 (human) APGSAPGSQYGTMTR S309
Abi-1 iso2 (human) APGSAPGsQYGTMTR S276-p
Abi-1 iso3 (human) APGsAPGsQyGTMTR S282-p
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) APGSAPGSQYGTMTR S326
Abi-1 (mouse) APGAAPGSQYGTMTR S282
Abi-1 iso4 (mouse) APGAAPGSQyGTMTR S276
Abi-1 (rat) APGAAPGSQYGTMTR S277
Y311
GSAPGSQYGTMTRQI
0 2
Abi-1 (human) GSAPGSQYGTMTRQI Y311
Abi-1 iso2 (human) GSAPGsQYGTMTRQI Y278
Abi-1 iso3 (human) GsAPGsQyGTMTRQI Y284-p
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) GSAPGSQYGTMTRQI Y328
Abi-1 (mouse) GAAPGSQYGTMTRQI Y284
Abi-1 iso4 (mouse) GAAPGSQyGTMTRQI Y278-p
Abi-1 (rat) GAAPGSQYGTMTRQI Y279
S319-p
GTMTRQIsRHNstts
0 67
Abi-1 (human) GTMTRQIsRHNstts S319-p
Abi-1 iso2 (human) GTMTRQISRHNSTTS S286
Abi-1 iso3 (human) GTMTRQISRHNSTTS S292
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) GTMTRQISRHNSTTS S336
Abi-1 (mouse) GTMTRQIsRHNsttS S292-p
Abi-1 iso4 (mouse) GTMTRQISRHNSTTS S286
Abi-1 (rat) GTMTRQISRHNSTTS S287
S323-p
RQIsRHNsttsstss
Upstream
0 355
Treatment
  • gefitinib
  • ischemia
Abi-1 (human) RQIsRHNsttsstss S323-p
Abi-1 iso2 (human) RQISRHNSTTSSTSS S290
Abi-1 iso3 (human) RQISRHNSTTSSTSS S296
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) RQISRHNSTTSSTSS S340
Abi-1 (mouse) RQIsRHNsttSsTSS S296-p
Abi-1 iso4 (mouse) RQISRHNSTTSSTSS S290
Abi-1 (rat) RQISRHNSTTSSTSS S291
T324-p
QIsRHNsttsstssG
0 41
Abi-1 (human) QIsRHNsttsstssG T324-p
Abi-1 iso2 (human) QISRHNSTTSSTSSG T291
Abi-1 iso3 (human) QISRHNSTTSSTSSG T297
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) QISRHNSTTSSTSSG T341
Abi-1 (mouse) QIsRHNsttSsTSSG T297-p
Abi-1 iso4 (mouse) QISRHNSTTSSTSSG T291
Abi-1 (rat) QISRHNSTTSSTSSG T292
T325-p
IsRHNsttsstssGG
0 14
Abi-1 (human) IsRHNsttsstssGG T325-p
Abi-1 iso2 (human) ISRHNSTTSSTSSGG T292
Abi-1 iso3 (human) ISRHNSTTSSTSSGG T298
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) ISRHNSTTSSTSSGG T342
Abi-1 (mouse) IsRHNsttSsTSSGG T298-p
Abi-1 iso4 (mouse) ISRHNSTTSSTSSGG T292
Abi-1 (rat) ISRHNSTTSSTSSGG T293
S326-p
sRHNsttsstssGGy
0 13
Abi-1 (human) sRHNsttsstssGGy S326-p
Abi-1 iso2 (human) SRHNSTTSSTSSGGY S293
Abi-1 iso3 (human) SRHNSTTSSTSSGGY S299
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) SRHNSTTSSTSSGGY S343
Abi-1 (mouse) sRHNsttSsTSSGGy S299
Abi-1 iso4 (mouse) SRHNSTTSSTSSGGY S293
Abi-1 (rat) SRHNSTTSSTSSGGY S294
S327-p
RHNsttsstssGGyR
0 6
Abi-1 (human) RHNsttsstssGGyR S327-p
Abi-1 iso2 (human) RHNSTTSSTSSGGYR S294
Abi-1 iso3 (human) RHNSTTSSTSSGGYR S300
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) RHNSTTSSTSSGGYR S344
Abi-1 (mouse) RHNsttSsTSSGGyR S300-p
Abi-1 iso4 (mouse) RHNSTTSSTSSGGYR S294
Abi-1 (rat) RHNSTTSSTSSGGYR S295
T328-p
HNsttsstssGGyRR
0 3
Abi-1 (human) HNsttsstssGGyRR T328-p
Abi-1 iso2 (human) HNSTTSSTSSGGYRR T295
Abi-1 iso3 (human) HNSTTSSTSSGGYRR T301
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) HNSTTSSTSSGGYRR T345
Abi-1 (mouse) HNsttSsTSSGGyRR T301
Abi-1 iso4 (mouse) HNSTTSSTSSGGYRR T295
Abi-1 (rat) HNSTTSSTSSGGYRR T296
S329-p
NsttsstssGGyRRt
0 8
Abi-1 (human) NsttsstssGGyRRt S329-p
Abi-1 iso2 (human) NSTTSSTSSGGYRRT S296
Abi-1 iso3 (human) NSTTSSTSSGGYRRT S302
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) NSTTSSTSSGGYRRT S346
Abi-1 (mouse) NsttSsTSSGGyRRT S302
Abi-1 iso4 (mouse) NSTTSSTSSGGYRRT S296
Abi-1 (rat) NSTTSSTSSGGYRRT S297
S330-p
sttsstssGGyRRtP
0 7
Abi-1 (human) sttsstssGGyRRtP S330-p
Abi-1 iso2 (human) STTSSTSSGGYRRTP S297
Abi-1 iso3 (human) STTSSTSSGGYRRTP S303
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) STTSSTSSGGYRRTP S347
Abi-1 (mouse) sttSsTSSGGyRRTP S303
Abi-1 iso4 (mouse) STTSSTSSGGYRRTP S297
Abi-1 (rat) STTSSTSSGGYRRTP S298
Y333-p
sstssGGyRRtPsVT
Upstream
0 88
Treatment
  • ephrin_B2
Abi-1 (human) sstssGGyRRtPsVT Y333-p
Abi-1 iso2 (human) SSTSSGGYRRTPSVT Y300
Abi-1 iso3 (human) SSTSSGGYRRTPSVT Y306
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) SSTSSGGYRRTPSVT Y350
Abi-1 (mouse) SsTSSGGyRRTPSVA Y306-p
Abi-1 iso4 (mouse) SSTSSGGYRRTPSVA Y300
Abi-1 (rat) SSTSSGGYRRTPSVT Y301
T336-p
ssGGyRRtPsVTAQF
0 6
Abi-1 (human) ssGGyRRtPsVTAQF T336-p
Abi-1 iso2 (human) SSGGYRRTPSVTAQF T303
Abi-1 iso3 (human) SSGGYRRTPSVTAQF T309
Abi-1 iso11 (human) gap -
Abi-1 iso12 (human) SSGGYRRTPSVTAQF T353
Abi-1 (mouse) SSGGyRRTPSVAAQF T309
Abi-1 iso4 (mouse) SSGGYRRTPSVAAQF T303